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chow. Both treatments resulted in reduced huCRP levels, indicative for
their anti-inﬂammatory action. Furthermore, a positive correlation was
found between the relative individual induction of huCRP evoked by
HFD at day 3 and end point OA grade. Leptin and resistin levels did not
correlate with OA severity.
Conclusions: HFD-induced OA in mice is due to low grade inﬂammation
and not the consequence of mechanical overload, since no relation
between body weight and OA grade was observed. Moreover, the OA
process was inhibited to a great extent by treatment with two drugs with
anti-inﬂammatory properties. The inﬂammatory response to a metabolic
high fat challenge may predict the individual susceptibility to develop OA
later in life. The use of statins or PPARg-agonists (such as rosiglitazone)
could be a strategy to interfere in the progression of OA.
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EFFECT OF THE SELECTIVE CATHEPSIN K INHIBITOR, MIV-711,
ON MARKERS OF CARTILAGE DEGRADATION AND ON GROSS AND
HISTOPATHOLOGY SCORES IN DOGS SUBJECTED TO PARTIAL MEDIAL
MENISCECTOMY, AN EXPERIMENTAL MODEL OF OSTEOARTHRITIS
E. Lindstrom1, L. Vrang1, S. Sedig1, Y. Terelius1, K. Wikstro¨m1,
B-L. Sahlberg1, T. Chambers2, D. Maul3, A. Bendele4, U. Grabowska1.
1Medivir AB, Huddinge, Sweden; 2St.George’s, Univ. of London, London,
United Kingdom; 3PCRS Inc., Fort Collins, CO, USA; 4Bolder BioPATH Inc,
Boulder, CO, USA
Purpose: Cathepsin K is a cysteine protease capable of degrading several
bone and cartilage matrix components. Previously, a pan-cathepsin
inhibitor provided cartilage-protective effects in dogs subjected to partial
medial meniscectomy, an experimental model of osteoarthritis (OA). In
the current study we evaluated MIV-711, a potent (Ki: 0.98 nM) and
highly selective cathepsin K inhibitor (>1,000-fold selectivity vs. related
cathepsin enzymes) in the same model.
Methods: Female beagle dogs were subjected to partial medial
meniscectomy of the left knee and were treated with either vehicle
(n = 15) or MIV-711 (n =15) at 30mmol/kg (17mg/kg) once daily starting
the day before surgery. Treatment continued for 28 days after surgery
followed by necropsy on day 29. Plasma, synovial ﬂuid and urinary
samples were collected at various time points during the experiment
and at necropsy. Biomarkers of collagen degradation were measured
using commercially available ELISA kits. Gross and microscopic changes
of the femorotibial joints were assessed.
Results: MIV-711 signiﬁcantly reduced CTX-II levels (marker of cartilage
degradation) in urine (by 80%, p < 0.001) compared to baseline and by
61% (p < 0.001) compared to vehicle. Synovial ﬂuid levels of CTX-II in both
knees were also signiﬁcantly reduced by 55–57%, (p < 0.001) compared
to baseline and by 31–36% (p < 0.01) compared to vehicle. Synovial levels
of MIV-711 were signiﬁcantly higher in the operated left knee than in
the right knee. Subjective and calculated gross pathology scores were
reduced by 25–37% in the femur and in the tibia by 13–37%in MIV-
711-treated animals compared to vehicle. Total lesion area in the tibia
was 26% lower in MIV-711-treated animals and the most severe lesion
area was reduced by 75%. Various scores of tibia cartilage histopathology
were 9–17% lower in the tibia of MIV-treated dogs.
Conclusions: We have previously shown that once daily oral dosing
of MIV-711 in dogs subjected to partial medial meniscectomy had a
positive effect on markers of bone resorption while maintaining markers
of bone formation. The present results now show that selective cathepsin
K inhibition achieved by once daily oral dosing with MIV-711 affects
markers of cartilage degeneration in a dog OA model. Taken together,
these data suggest MIV-711 may be beneﬁcial not only for treatment of
osteoporosis but also for OA.
113
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CONGENITA MUTATION AS A MODEL FOR OSTEOARTHRITIS
D.W. Macdonald1, J. Farrell1, N. Heimann1, D.W. Holt1, D. Kooyman1,
R.E. Seegmiller1,2. 1Brigham Young Univ., Provo, UT, USA; 2Roseman Univ.
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Purpose: Osteoarthritis (OA) is one of the leading causes of joint pain
and disability in the United States. There is a lack of effective treatments
for the disease because of a poor understanding of its pathogenesis.
Murine models, such as spondyloepiphyseal dysplasia congenita (sedc),
are important in further understanding OA. The purposes of the present
study are to (1) establish the homozygous sedc mutation (s/s) as a
model of osteoarthritis; (2) characterize the articular cartilage in sedc
mice by identifying cellular changes over time and localizing the major
structural proteins present in the extracellular matrix; (3) to identify a
possible mechanism involved in the pathogenesis of OA.
Methods: Knee and temporomandibular joints of homozygous wild-
type (+/+) and homozygous sedc (s/s) mice were compared histologically
at 2, 6 and 9 months. The mice were euthanized and their tissues
were prepared and stained using Fast Green and Safranin O to
show the presence and localization of proteoglycans and collagen.
Immunohistochemical staining (IHC) for Ddr2 and Mmp-13 was also
performed to detect changes in the presence of both of these degradative
proteins. In addition, toluidine blue stained sections were analyzed to
determine the matrix vs. chondron area in both the mutant and the
wild-type mice. TEM photomicrographs were taken for comparison of
cell diameter, pericellular matrix and ﬁbril diameter.
Results: Histological analysis of the mutant showed increased
pericellular space and disorganization of the chondrocytes. Rather than
superﬁcial ﬁssuring as seen in the sedc heterozygous model, the sedc
homozygous mice displayed increased ﬁssuring only along the tidemark
that separates calciﬁed from non-calciﬁed cartilage. Homozygous mutant
mice displayed increased cartilage separation, increased pericellular
diameter, increased proteoglycan staining, and cell clustering as early
as 2 months. IHC staining showed a lack of upregulated Ddr2 and
Mmp-13 in mutant mice. TEM of the mutant showed atypical cell
morphology including cytoplasmic membrane extensions, amorphous
material in the pericellular matrix and smaller diameter collagen ﬁbrils
in the interterritorial matrix.
Conclusions: Homozygous sedc mice develop premature OA in
comparison with wild-type contols. Therefore, the homozygous mutant
presents itself a valuable murine model of the study of OA. However,
the s/s mouse is unlike other OA models in that the tissue degeneration
does not appear to be typical of other models that invoke the enzymatic
degredation pathway involving Ddr2, HtrA1 and Mmp-13.
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OSTEOARTHRITIS-LIKE CHANGES IN THE MURINE KNEE JOINT BY
MEANS OF FORCED RUNNING
K. Hashimoto, M. Akagi. KINKI Univ., osakasayama, Japan
Purpose: Various murine knee osteoarthritis(OA)models are known.
However, few non-invasive model has been developed. In this study, we
developed murine knee OA model with forced running on the treadmill
and evaluate the OA-like changes by X-ray and histology.
Methods: To 9-week old CB57/BL6 mice, forced running were applied
3 times a week (15minutes a once; running distance=165m). At 2, 4, 6,
8 weeks, the knee joints were excised and morphologically analyzed with
magniﬁed X-ray.Further, they were subjected to histological analysis (HE,
Safranin-O, Toluidine blue).OARSI score was used to semi-quantitative
evaluation.And they were immunostained by typeII, X collagen.
